{"gao_id": "GAO-08-224T", "published": "2007-11-01T13:00:00Z", "released": "2007-11-01T09:00:00Z", "summary": "", "title": "Drug Safety: Preliminary Findings Suggest Weaknesses in FDA's Program for Inspecting Foreign Drug Manufacturers", "topics": ["Risk assessment", "International relations", "Data integrity", "Food and drug legislation", "Product safety", "Pharmaceutical industry", "Imported drugs", "Program implementation", "Inspection", "Foreign governments", "Accountability", "Investigations by federal agencies", "Prescription drugs", "Program management", "Importing", "Health Care", "Databases"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-08-224t", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-08-224t-highlights.pdf"}, {"title": "Full Report (28 pages)", "url": "https://www.gao.gov/assets/gao-08-224t.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a118466.html"}]}